237 related articles for article (PubMed ID: 35962329)
1. Farnesyl diphosphate synthase regulated endothelial proliferation and autophagy during rat pulmonary arterial hypertension induced by monocrotaline.
Jin T; Lu J; Lv Q; Gong Y; Feng Z; Ying H; Wang M; Fu G; Jiang D
Mol Med; 2022 Aug; 28(1):94. PubMed ID: 35962329
[TBL] [Abstract][Full Text] [Related]
2. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
4. A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
Xue Z; Zhou M; Liu Y; Qin H; Li Y; Zhu Y; Yang J
J Ethnopharmacol; 2023 Oct; 314():116544. PubMed ID: 37088239
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor-α-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
Li J; He X; Liu F; Zheng X; Jiang J
J Cardiovasc Pharmacol; 2024 Jan; 83(1):73-85. PubMed ID: 38180455
[TBL] [Abstract][Full Text] [Related]
7. Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K/Akt/eNOS signaling.
Zheng Z; Yu S; Zhang W; Peng Y; Pu M; Kang T; Zeng J; Yu Y; Li G
Histol Histopathol; 2017 Jan; 32(1):35-41. PubMed ID: 27087006
[TBL] [Abstract][Full Text] [Related]
8. miR‑371b‑5p inhibits endothelial cell apoptosis in monocrotaline‑induced pulmonary arterial hypertension via PTEN/PI3K/Akt signaling pathways.
Zhu G; Zhang W; Liu Y; Wang S
Mol Med Rep; 2018 Dec; 18(6):5489-5501. PubMed ID: 30387816
[TBL] [Abstract][Full Text] [Related]
9. Silencing TUFM Inhibits Development of Monocrotaline-Induced Pulmonary Hypertension by Regulating Mitochondrial Autophagy via AMPK/mTOR Signal Pathway.
Wei R; Lv X; Fang C; Liu C; Ma Z; Liu K
Oxid Med Cell Longev; 2022; 2022():4931611. PubMed ID: 35936222
[TBL] [Abstract][Full Text] [Related]
10. Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway.
Yin Q; Wang S; Yang J; Fan C; Yu Y; Li J; Mei F; Zhang S; Xi R; Zhang X
J Pharm Pharmacol; 2023 Aug; 75(8):1100-1110. PubMed ID: 37158759
[TBL] [Abstract][Full Text] [Related]
11. Dacomitinib, a new pan-EGFR inhibitor, is effective in attenuating pulmonary vascular remodeling and pulmonary hypertension.
Yu X; Zhao X; Zhang J; Li Y; Sheng P; Ma C; Zhang L; Hao X; Zheng X; Xing Y; Qiao H; Qu L; Zhu D
Eur J Pharmacol; 2019 May; 850():97-108. PubMed ID: 30753867
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
Sahara M; Sata M; Morita T; Hirata Y; Nagai R
PLoS One; 2012; 7(3):e33367. PubMed ID: 22479390
[TBL] [Abstract][Full Text] [Related]
13. [Tanshinone IIA alleviates monocrotaline-induced pulmonary hypertension in rats through the PI3K/Akt-eNOS signaling pathway].
Zhang X; Liu S; Sun Y; Li G
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):718-723. PubMed ID: 35673916
[TBL] [Abstract][Full Text] [Related]
14. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
Chen YJ; Li HF; Zhao FR; Yu M; Pan SY; Sun WZ; Yin YY; Zhu TT
Int Immunopharmacol; 2024 May; 132():111946. PubMed ID: 38552292
[TBL] [Abstract][Full Text] [Related]
15. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
[TBL] [Abstract][Full Text] [Related]
16. Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
Zhai C; Zhang N; Wang J; Cao M; Luan J; Liu H; Zhang Q; Zhu Y; Xue Y; Li S
Lung; 2022 Oct; 200(5):619-631. PubMed ID: 36107242
[TBL] [Abstract][Full Text] [Related]
17. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
[TBL] [Abstract][Full Text] [Related]
18. 3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
Guo Y; Liu X; Zhang Y; Qiu H; Ouyang F; He Y
Life Sci; 2020 Sep; 256():118009. PubMed ID: 32603819
[TBL] [Abstract][Full Text] [Related]
19. β-arrestin1 inhibits hypoxic injury-induced autophagy in human pulmonary artery endothelial cells via the Akt/mTOR signaling pathway.
Ning H; Deng J; Chen F; Liu Y; Kong D; Shan L; Zhang Z; Hu T
Int J Biochem Cell Biol; 2020 Aug; 125():105791. PubMed ID: 32544529
[TBL] [Abstract][Full Text] [Related]
20. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
Yang HT; Wang G; Zhu PC; Xiao ZY
Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
